QUESTION ASKED: What are the risk factors associated with 30-day potentially avoidable readmissions in patients with cancer?
INTRODUCTION
Avoidable hospital readmission is a widely recognized problem within the modern health care system because of its direct effects on patient outcomes and costs of care and because it represents a natural target for quality improvement efforts. Several studies have identified specific factors associated with hospital readmissions, but emerging data have demonstrated that the nature of the problem is both multifaceted and complex. Underlying diagnoses as well as comorbidities can influence the likelihood of a patient's hospital readmission in ways that remain incompletely understood. patients with cancer as another group at particular risk for readmission within 30 days of hospital discharge. 1 Evaluation of hospital readmissions within the oncology patient population presents a particular challenge for several reasons. First, many oncology hospitalizations are planned for the administration of elective chemotherapy and do not represent a failure of the system to prevent avoidable readmissions. Second, patient comorbidities are key factors that contribute to avoidable hospital readmissions. 1 Oncology patients may have multiple and complex comorbidities as a result of not only the etiology of their malignancy but also the expected, and thus incompletely preventable, complications of treatment. Finally, many oncology patients will face end-oflife decisions, another independently identified variable that can contribute to potentially avoidable readmissions. 4 Overall, oncology patients represent a large and growing complex and medically vulnerable population. Identification of specific risk factors associated with potentially avoidable readmissions in this population may allow for more targeted interventions to prevent readmissions and thereby improve disease outcomes, quality of life, and cost-effective delivery of care. We used a retrospective cohort of consecutive adult patient discharges from an academic tertiary hospital with a large inpatient oncology census to identify specific risk factors associated with 30-day potentially avoidable readmissions.
METHODS AND MATERIALS

Study Design and Population
We included all consecutive adult patients discharged from the oncology service of the Brigham and Women's Hospital (BWH)/Dana-Farber Cancer Institute (DFCI) between July 1, 2009, and June 30, 2010. BWH is a 750-bed academic medical center in Boston, Massachusetts. DFCI is a National Cancer Institute-designated Comprehensive Cancer Center. Since 1997, all DFCI inpatients are hospitalized within BWH. Hospital stays of # 24 h were not included because they are mainly observational stays. We excluded patients who died before discharge of the index hospitalization, were transferred to another acute health care facility, or left against medical advice. We excluded patients who died during the index hospitalization because they were no longer at risk for readmission, and we excluded patients who were transferred to another health care facility because the risk of readmission must be measured at the time of discharge from the second facility and based on that facility's data. The study protocol was approved by the institutional review board of BWH/ Partners Healthcare.
Study Outcome
The study outcome was any 30-day potentially avoidable readmission to any service of three hospitals within the Partners Healthcare network, which were BWH, Massachusetts General Hospital (a 1,000-bed tertiary care hospital), and Faulkner Hospital (a 150-bed community hospital closely affiliated with BWH). More than 80% of all readmissions after an index medical admission to BWH are captured within this network. 5, 6 We identified readmissions deemed potentially avoidable with a validated algorithm (SQLape, Corseaux, Switzerland) that uses administrative data, mainly diagnostic and procedure codes of both index admission and readmission. 7, 8 The algorithm excludes unavoidable foreseen readmissions, such as those for chemotherapy or radiotherapy, transplantation, labor and delivery, and other specific surgical procedures. Follow-up and rehabilitation treatments also are considered unavoidable.
Readmissions for a disease that occurred in a new organ system (eg, circulatory, respiratory, digestive, hepatic, nervous, blood) not affected during the index hospitalization were also considered unavoidable. Readmissions related to specific difficult-to-cure diseases (eg, multiple sclerosis, idiopathic thrombocytopenia) were considered unavoidable. Conversely, complications of treatment, such as deep vein thrombosis or catheter-associated urinary tract infection, were considered potentially avoidable, 8 as were other readmissions that involve an organ system affected during the index hospitalization. The sensitivity and the specificity of the screening algorithm reached 96% compared with medical chart review (with use of the same criteria) in a random sample of admission-readmission pairs. 9 We chose the SQLape algorithm because it was the only available tool to our knowledge that differentiates unavoidable from potentially avoidable readmissions.
Predictor Variables
We collected data on several types of variables from easily obtainable sources (Table 1) , including demographic information, previous health care use, primary care provider information, and index admission characteristics from administrative data sources; procedures and chronic medical conditions from billing data; and last known laboratory values before discharge from the Partners Healthcare clinical data 
Statistical Analysis
Patient baseline characteristics are presented as proportions, means with standard deviations, and medians with interquartile ranges (IQRs) as appropriate. The unit of analysis was any patient's index discharge from the oncology service.
The presence of any difference in baseline characteristics between the groups with a 30-day potentially avoidable readmission and those not readmitted at all was first tested by bivariable logistic regression. We then performed a multivariable logistic regression in which the final model included variables found to be significantly associated with the outcome in bivariable testing at the P = .05 level. The time to 
RESULTS
Among the 3,505 patients discharged from the oncology division, 399 were excluded because they were transferred to another acute health care facility, 185 because they died, and five because they left against medical advice. Of the remaining 2,916 patient discharges, 1,086 (37.3%) were followed by a readmission within 30 days. Of these, 341 (31.4% of all readmissions, 11.7% of all discharges) were identified as potentially avoidable (Appendix Fig A1, online only) . Table 1 compares the baseline characteristics between the patients who did not have a 30-day readmission and those who had a 30-day potentially avoidable readmission.
From the bivariable analysis, the following factors were associated with a 30-day potentially avoidable readmission at the .10 significance level: length of stay, number of admissions in the previous 12 months, urgent or emergent index hospitalization, total number of medications on discharge, opiate medication use at discharge, anticoagulation at discharge, Elixhauser comorbidity index, hemoglobin level at discharge, sodium level at discharge, hematologic neoplasm, metastatic neoplasm, ovarian neoplasm, congestive heart failure, and liver disease. In the multivariable analysis, the following risk factors remained significantly and independently associated with a potentially avoidable readmission: total number of medications at discharge, liver disease, sodium level at discharge, and hemoglobin level at discharge ( Table 2 ).
The five most frequent primary diagnoses at readmission were neoplasm, infection, nutritional and metabolic disorder, GI disorder, and renal failure (Table 3) . Of note, these were five of the top six primary diagnoses for the index hospitalization ( Table 1 ). The median time of occurrence of 30-day potentially avoidable readmissions was 10 (IQR, 9 to 11) days versus 13 (IQR, 12 to 14) days for 30-day unavoidable readmissions (P , .001). The median time of 30-day potentially avoidable readmission varied from 4 to 12 days according to the primary diagnosis of readmission (Table 3) . Readmissions due to adverse drug events, GI disorders, renal failure, or infection tended to occur earlier, whereas readmissions due to nutritional or metabolic disorders, heart failure, and thrombosis occurred later.
DISCUSSION
In this cohort of 2,916 patients with cancer, we found that almost 40% were readmitted within 30 days and that approximately one third of these readmissions were considered potentially preventable. Several factors were identified as independently associated with 30-day potentially avoidable readmission, including the total number of medications at discharge, liver disease, last sodium level, and last hemoglobin level before discharge. Of note, potentially avoidable readmissions occurred significantly earlier than unavoidable readmissions, with time to readmission varying substantially according to the readmission diagnosis.
Patients with cancer have a particularly high risk for readmission, 2,13 but the characteristics of this population are not clear. The majority of the studies on readmission among patients with cancer looked at surgical patients with postoperative readmission for specific cancers. [14] [15] [16] [17] [18] [19] Much less is known about the readmission characteristics for general patients with cancer hospitalized within a medical or oncology service. [20] [21] [22] Many of the potentially avoidable readmissions in this study simply represent progression of disease or unavoidable adverse effects of treatment (and thus, are not truly preventable). However, as in other studies that used the SQLape algorithm, those with potentially avoidable readmissions should be thought of as a population enriched for patients whose readmissions might have been prevented with more-intensive transitional care activities.
The risk factors identified in this study seem plausible. The total number of medications likely represents a proxy for patient comorbidities and/or higher risk for readmission due to adverse drug events. Liver disease in patients with cancer may represent metastatic disease, which carries a poor prognosis as well as a risk for bleeding, infection, hepatic encephalopathy, and other complications of cirrhosis. Low sodium level is associated with poor outcomes in many disease states [23] [24] [25] [26] and may reflect a higher risk due to comorbidities that cause hyponatremia (eg, heart failure), chemotherapy-induced dehydration, or syndrome of inappropriate antidiuretic hormone secretion due to total cancer burden or lung or brain involvement.
Finally, a low hemoglobin may reflect bone marrow suppression associated with certain chemotherapies, poor nutritional status, and/or anemia of chronic inflammation. Most of these risk factors are not modifiable, however, and we do not imply that by addressing these risk factors themselves, even if they are modifiable, postdischarge outcomes would be improved. However, these risk factors identify patients who may benefit from intensive transitional care interventions. The study has several limitations. First, we included in the analysis only predictors easily obtainable from electronic data sources. We cannot exclude the presence of other important risk factors for readmission, such as the functional status of the patient. In addition, we were not able to capture the stage of the cancer. On the basis of the available data, we show that metastatic neoplasm was not an independent risk factor for 30-day potentially avoidable readmission in multivariable analysis. This finding suggests that the stage may not be as important as expected, but we acknowledge that this coding is an imperfect proxy for cancer stage and that further studies are needed to explore this particular relationship. Second, no gold standard is available for the definition of preventable readmission. The identification of potentially avoidable readmission with the SQLape algorithm is not perfect, and whether the algorithm is any more or less diagnostic for oncology patients than any other category of hospitalized medical patients is unknown. However, SQLape has been used in numerous other studies; uses clear and logical criteria, which allow for reproducibility and reliability in the analysis of large databases; and is useful for identifying risk factors. The study may have been underpowered to identify all clinically important risk factors. We do not have information to draw conclusions about whether the risk factors for potentially avoidable readmission differ for patients readmitted to a different hospital from the site of their index hospitalization. Finally, this single-center study was from an academic hospital with a major cancer institute, and results might not be generalizable to other settings. Next steps could include detailed medical record review to determine the true preventability of these readmissions, identify potentially actionable risk factors unique to this population, and better understand the differences in time to readmission among various populations.
In conclusion, readmission in this large cohort of patients with cancer was frequent, with approximately one third of readmissions deemed potentially preventable. Risk factors associated with 30-day potentially avoidable readmission are the number of medications, liver disease, and low sodium and hemoglobin levels. Patients discharged with these factors could benefit from transitional care interventions.
